Reducing HIV stigma to improve treatment access for drug users
Part of Immune system & allergy, Infections clinical trials.
This study tests whether reducing stigma and discrimination against people who use drugs can help more people access HIV treatment and prevention. You would participate in peer-led group sessions and surveys over 18 months to help researchers understand how stigma affects treatment access in Bishkek.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You've injected drugs or used drugs with someone who injects in the past 12 months
- You're currently using illicit drugs (including opioids, synthetics, or prescription drugs not as prescribed)
- You're 18 years or older
- You live in one of two specific districts in Bishkek
- You don't plan to move away from Bishkek for at least 18 months
- You test negative for HIV at the start of the study
- You can commit to five peer-led group sessions and four surveys over 18 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a program can reduce shame and stigma for people living with HIV who also have a substance use disorder. It may help you feel less judged and cope better, while supporting HIV care.
This project studies how to improve offering and completing HIV (and hepatitis C) tests in opioid treatment programs. It may help increase timely follow-up and linkage to care when results are positive.
This study looks at whether getting support from friends and peers who also use drugs can help people start HIV prevention (PrEP) and treatment for substance use. The goal is to make it easier for people who inject drugs to get the care they need.
This trial helps young people aged 18 to 24 living with HIV in three districts of Zambia. It aims to reduce stigma and build job skills to improve their lives.
This study looks at whether starting HIV treatment on the same day you are diagnosed helps reduce stigma and improves engagement in care. It involves interviews and surveys with patients and staff at two clinics in Peru.
This study tests how well a program combining telemedicine (virtual doctor visits) and peer support can help prevent HIV among people who inject drugs. You'd get trained, attend weekly group sessions, and invite a friend or partner to also take part.
Hear when a new HIV (Human Immunodeficiency Virus) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.